Magna International Inc. Stock Rises Tuesday, Still Underperforms Market
Dow Jones2026/10/27 20:34This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Magna International Inc. MG inched 0.50% higher to C$90.03 Tuesday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index rising 0.63% to 36,171.49.
Magna International Inc. closed 10.9% short of its 52-week high of C$101.10, which the company reached on August 5th.
Trading volume of 557,882 shares remained below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 27, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
